In ccRCC, OXPHOS dysfunction is a hallmark of metabolic reprogramming, notably through the suppression of PGC-1α, a crucial regulator of mitochondrial biogenesis and energy metabolism. This evidence concerns the gene PPARGC1A and nonpapillary renal cell carcinoma.